Skip to main content
Elinore Mccance-Katz, MD, Psychiatry, Providence, RI

ElinoreFMccance-KatzMD

Psychiatry • Providence, RI

Addiction

Chief Medical Officer, Substance Abuse and Mental Health Services Administration

Join to view full profile

Dr. Mccance-Katz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mccance-Katz's full profile

Already have an account?

  • Office

    345 Blackstone Blvd
    Providence, RI 02906
    Phone+1 401-455-6200
    Fax+1 401-455-6689

Education & Training

  • Institute of Living/Hartford Hospital
    Institute of Living/Hartford HospitalResidency, Psychiatry, 1988 - 1991
  • Duke University Hospital
    Duke University HospitalInternship, Transitional Year, 1987 - 1988
  • Uconn School Of Medicine
    Uconn School Of MedicineClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - 2026
  • RI State Medical License
    RI State Medical License 2015 - 2026
  • CT State Medical License
    CT State Medical License 1989 - 2025
  • VA State Medical License
    VA State Medical License 2002 - 2008
  • NY State Medical License
    NY State Medical License 1999 - 2002
  • NC State Medical License
    NC State Medical License 1987 - 1988
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Buprenorphine and Office-Based Treatment of Opioid Dependence 
    American Academy of Addiction Psychiatry(AAAP), Aventura, Florida - 12/10/2012
  • Healthcare in the 21st Century 
    University of California, San Francisco, California - 4/20/2012

Press Mentions

  • Is Marijuana Linked to Psychosis, Schizophrenia?
    Is Marijuana Linked to Psychosis, Schizophrenia?December 15th, 2019
  • Parental Marijuana Use Was Associated with Elevated Risk of Substance Use Among Adolescent and Young Adult Offspring Living in the Same Household
    Parental Marijuana Use Was Associated with Elevated Risk of Substance Use Among Adolescent and Young Adult Offspring Living in the Same HouseholdNovember 27th, 2019
  • Kids More Likely to Use Marijuana if Their Parents Do
    Kids More Likely to Use Marijuana if Their Parents DoNovember 26th, 2019
  • Join now to see all

Grant Support

  • Interaction Of Alcohol And Haart In HIV/AIDS And HIV/AIDS And HCV CoinfectionNational Institute On Alcohol Abuse And Alcoholism2008–2011
  • Role Of Buprenorphine In Improving Clinical Care In Opioid Addiction And HIVNational Institute On Drug Abuse2007–2011
  • Model For The Evaluation Of The Immunomodulatory Effects Of Opioid Addiction, WitNational Institute On Drug Abuse2008–2010
  • Disulfiram Interactions With HIV Medications: Clinical ImplicationsNational Institute On Drug Abuse2008–2010
  • Opioids &Hiv Medications: Interactions In Drug AbusersNational Institute On Drug Abuse2007–2008
  • Interaction Of HIV Medications With Opiate Therapy MedicationsNational Center For Research Resources2005–2008
  • Intravenous Cocaine Administration In The Presence Of Disulfiram In Humans: PharNational Center For Research Resources2006
  • Opioids &Hiv Medications: Interactions In Drug AbusersNational Institute On Drug Abuse2004–2006
  • The Effect Of Cocaethylene On Responses To CocaineNational Center For Research Resources2004–2006
  • Intravenous Cocaine Administration In The Presence Of Disulfiram In HumansNational Center For Research Resources2005
  • Enhancing Health Care Of Drug Users With HIVNational Institute On Drug Abuse2002–2005
  • Intravenous Cocaine Admin. In The Presence Of DisulfiramNational Center For Research Resources2004
  • Interaction Of HIV Medications With Opiate Therapy Meds.National Center For Research Resources2004
  • Opioids And HIV Medications--Interactions In Drug AbuserNational Institute On Drug Abuse2002–2003
  • Cocaine, Alcohol, And Cocaethylene--Clinical EffectsNational Institute On Drug Abuse2002
  • Cocaethylene Cocaine Agonist Therapy/Tolerance InductionNational Institute On Drug Abuse2002
  • Cocaine, Alcohol, And Cocaethylene--Clinical EffectsNational Institute On Drug Abuse2001–2002
  • Cocaethylene Cocaine Agonist Therapy/Tolerance InductionNational Institute On Drug Abuse2001–2002
  • Enhancing Health Care Of Drug Users With HIVNational Institute On Drug Abuse2001–2002
  • Opioids And HIV Medications--Interactions In Drug AbuserNational Institute On Drug Abuse1999–2002
  • Nelfinavir Effects On Opioid DispositionNational Center For Research Resources1999–2001
  • Opiate Dependence Pharmacotherapy Maintenance Effects On Zidovudine (AZT)National Center For Research Resources1998–2001
  • Cocaine, Alcohol, And Cocaethylene--Clinical EffectsNational Institute On Drug Abuse2000
  • Pharmacokinetics Of CocaethyleneNational Center For Research Resources1998–2000
  • Cocaine, Alcohol, And Cocaethylene--Clinical EffectsNational Institute On Drug Abuse1998
  • Cocaine &Alcohol Abuse--Psychophysiology &TreatmentNational Institute On Drug Abuse1998
  • Disulfiram For Cocaine/Alcohol AbuseNational Institute On Drug Abuse1996–1998
  • Cocaine &Alcohol Abuse--Psychophysiology &TreatmentNational Institute On Drug Abuse1994–1998
  • Repeated Cocaine Administration In The Presence Of Steady State EthanolNational Center For Research Resources1996–1997
  • Behavioral/Physicologicl Effects Of Disulfiram With CocaineNational Center For Research Resources1996–1997
  • Cocaine, Alcohol, And Cocaethylene--Clinical EffectsNational Institute On Drug Abuse1996

Dr. Elinore Mccance-Katz, Dr. Elinore Mccance-Katz, MD, Dr. E Mccance-Katz, Dr. Elinore F Mccance-Katz